Rafferty Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.06M | Sell |
98,305
-38,368
| -28% | -$2.96M | 0.03% | 298 |
|
|
2025
Q4 | $10.8M | Sell |
136,673
-4,119
| -3% | -$325K | 0.04% | 253 |
|
|
2025
Q3 | $10.6M | Buy |
140,792
+7,077
| +5% | +$485K | 0.03% | 266 |
|
|
2025
Q2 | $9.22M | Buy |
133,715
+16,976
| +15% | +$1.11M | 0.03% | 292 |
|
|
2025
Q1 | $7.91M | Sell |
116,739
-25,978
| -18% | -$1.55M | 0.03% | 297 |
|
|
2024
Q4 | $6.41M | Buy |
142,717
+15,126
| +12% | +$849K | 0.02% | 366 |
|
|
2024
Q3 | $8.02M | Sell |
127,591
-8,949
| -7% | -$522K | 0.03% | 317 |
|
|
2024
Q2 | $8.06M | Buy |
136,540
+6,656
| +5% | +$416K | 0.03% | 316 |
|
|
2024
Q1 | $10.4M | Sell |
129,884
-854
| -0.7% | -$65.2K | 0.04% | 259 |
|
|
2023
Q4 | $10.3M | Sell |
130,738
-3,280
| -2% | -$233K | 0.04% | 269 |
|
|
2023
Q3 | $9.36M | Buy |
134,018
+9,961
| +8% | +$706K | 0.06% | 242 |
|
|
2023
Q2 | $8.58M | Buy |
124,057
+9,159
| +8% | +$652K | 0.05% | 243 |
|
|
2023
Q1 | $8.54M | Buy |
114,898
+1,858
| +2% | +$156K | 0.06% | 224 |
|
|
2022
Q4 | $10.5M | Buy |
113,040
+42,840
| +61% | +$4.13M | 0.09% | 172 |
|
|
2022
Q3 | $6.7M | Buy |
70,200
+38,384
| +121% | +$3.8M | 0.07% | 237 |
|
|
2022
Q2 | $2.95M | Sell |
31,816
-8,304
| -21% | -$810K | 0.03% | 398 |
|
|
2022
Q1 | $4.06M | Sell |
40,120
-4,248
| -10% | -$446K | 0.02% | 426 |
|
|
2021
Q4 | $4.58M | Buy |
44,368
+2,296
| +5% | +$212K | 0.02% | 420 |
|
|
2021
Q3 | $3.57M | Buy |
42,072
+14,820
| +54% | +$1.24M | 0.02% | 398 |
|
|
2021
Q2 | $2.27M | Buy |
27,252
+1,113
| +4% | +$91.1K | 0.01% | 651 |
|
|
2021
Q1 | $1.97M | Buy |
26,139
+3,170
| +14% | +$231K | 0.01% | 634 |
|
|
2020
Q4 | $1.57M | Sell |
22,969
-3,324
| -13% | -$216K | 0.02% | 438 |
|
|
2020
Q3 | $1.54M | Sell |
26,293
-5,328
| -17% | -$332K | 0.02% | 490 |
|
|
2020
Q2 | $2.05M | Buy |
31,621
+21,608
| +216% | +$1.36M | 0.03% | 347 |
|
|
2020
Q1 | $594K | Sell |
10,013
-25,118
| -71% | -$1.68M | 0.02% | 304 |
|
|
2019
Q4 | $2.61M | Buy |
+35,131
| New | +$2.47M | 0.04% | 265 |
|
|
2018
Q3 | – | Sell |
-56,405
| Closed | -$3.63M | – | 700 |
|
|
2018
Q2 | $3.63M | Buy |
+56,405
| New | +$3.72M | 0.05% | 177 |
|
|
2018
Q1 | – | Sell |
-4,266
| Closed | -$309K | – | 682 |
|
|
2017
Q4 | $309K | Buy |
+4,266
| New | +$310K | 0.01% | 641 |
|
|
2015
Q3 | – | Sell |
-5,791
| Closed | -$607K | – | 560 |
|
|
2015
Q2 | $607K | Buy |
5,791
+3,250
| +128% | +$332K | 0.04% | 309 |
|
|
2015
Q1 | $262K | Buy |
+2,541
| New | +$257K | 0.02% | 465 |
|
|
2014
Q4 | – | Sell |
-2,547
| Closed | -$203K | – | 355 |
|
|
2014
Q3 | $203K | Buy |
+2,547
| New | +$201K | 0.02% | 342 |
|
Other funds holding CVS
VCM
VPM
Rafferty Asset Management's CVS Position: Q1 2026 in Review
Rafferty Asset Management reduced its CVS Health (CVS) stake by 28% in Q1 2026, selling an estimated $2.96M and leaving 98,305 shares worth $7.06M. The position accounts for 0.03% of the portfolio, ranked #298.
Rafferty Asset Management first reported a position in CVS in Q3 2014 and has held it in 31 quarters since. The position peaked at $10.8M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Rafferty Asset Management held 98,305 shares of CVS Health worth $7.06M as of Q1 2026.
- Rafferty Asset Management sold 38,368 CVS Health shares in Q1 2026, an estimated $2.96M.
- CVS Health made up 0.03% of Rafferty Asset Management's portfolio in Q1 2026, its #298 holding.
- Rafferty Asset Management first reported a position in CVS Health in Q3 2014 and has held it in 31 quarters since.
- Rafferty Asset Management's CVS Health position peaked at $10.8M in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.